Who is sponsoring NCT05345782?

NCT05345782 is sponsored by Ain Shams University.

What drugs are being tested in NCT05345782?

Interventions in NCT05345782: MARCAINE AND BETAMETHAZONE 1, MARCAINE AND BETAMETHAZONE 2.

What condition does NCT05345782 study?

NCT05345782 studies Chronic Idiopathic Pain Syndrome.

Is NCT05345782 still recruiting?

NCT05345782 is currently status unknown. Last updated 6 April 2023.

Last reviewed 2023-04-06 · How we verify

NCT05345782

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laparoscopic Combined Hypo Gastric Neural Plexus Block and Uterosacral Nerve Block for Patients With Chronic Idiopathic Pelvic Pain

Status unknown NA Last updated 6 April 2023

What this trial tests

NA trial testing MARCAINE AND BETAMETHAZONE 1 in Chronic Idiopathic Pain Syndrome in 60 participants. Status unknown.

Timeline

20 April 2022

Primary endpoint
26 April 2023

26 April 2023

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	20 April 2022
Primary completion	26 April 2023
Estimated completion	26 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

MARCAINE AND BETAMETHAZONE 1 — full drug profile →
MARCAINE AND BETAMETHAZONE 2 — full drug profile →

Conditions studied

Chronic Idiopathic Pain Syndrome — all drugs for Chronic Idiopathic Pain Syndrome →

Sponsor

Ain Shams University

Who can join

Adults 18 to 50, any sex, with Chronic Idiopathic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Often the etiology of chronic pelvic pain is not clear, as there are many disorders of the reproductive tract, gastrointestinal system, urological organs, musculoskeletal system, and psych neurological system that may be associated with chronic pelvic pain. An effective treatment for this condition has evaded the medical profession for centuries. Even today only 20-25% patients respond to conservative management.5 When such treatment fails, a diagnostic laparoscopy is performed.1, 3, 6 the cause of the pain is not always obvious as no pathology is seen in 40-60% of the cases.1

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05345782 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 6 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05345782.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing